| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.71B | +30.7% |
| Cost of Revenue | $768.2M | +22.7% |
| Gross Profit | $1.94B | +34.2% |
| R&D Expense | $301.1M | +37.1% |
| SG&A Expense | $1.17B | +27.0% |
| Operating Income | $473.8M | +53.4% |
| Pre-tax Income | $339.5M | +13.1% |
| Income Tax | $92.4M | +178.2% |
| Net Income | $247.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Inventory | $452.6M | +5.2% |
| Current Assets | $1.91B | +1.2% |
| Total Assets | $3.19B | +3.3% |
| Current Liabilities | $680.1M | +28.7% |
| Long-term Debt | $930.8M | -28.2% |
| Total Liabilities | $1.68B | -10.7% |
| Stockholders' Equity | $1.52B | +25.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $569.3M | +32.3% |
| Capital Expenditures | $191.6M | +53.4% |
| Investing Cash Flow | -$222.7M | -52.3% |
| Financing Cash Flow | -$595.3M | -2018.5% |
| Free Cash Flow | $377.7M | +23.7% |
| -40.9% |
| EPS (Basic) | $3.51 | -41.2% |
| EPS (Diluted) | $3.48 | -39.8% |